These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 8271055)

  • 1. PET studies in psychiatry: validity, accuracy and future.
    Vallabhajosula S; Buchsbaum M
    J Nucl Med; 1994 Jan; 35(1):24-6. PubMed ID: 8271055
    [No Abstract]   [Full Text] [Related]  

  • 2. Positron emission tomography in dementia.
    Santens P; Petit H
    Acta Neurol Belg; 1997 Sep; 97(3):192-5. PubMed ID: 9345592
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Is leuko-araiosis in Alzheimer's disease, in Parkinson's disease and in healthy elderly persons the result of Wallerian degeneration?].
    Leys D; Pruvo JP; Soetaert G; Vermersch P; Rapoport A; Clarisse J; Petit H
    Acta Neurol Belg; 1989; 89(3-4):249-52. PubMed ID: 2516973
    [No Abstract]   [Full Text] [Related]  

  • 4. Atlas of dopamine receptor images (PET) of the human brain.
    Inoue Y; Wagner HN; Wong DF; Links JM; Frost JJ; Dannals RF; Rosenbaum AE; Takeda K; Di Chiro G; Kuhar MJ
    J Comput Assist Tomogr; 1985; 9(1):129-40. PubMed ID: 3155755
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The detection of preclinical Parkinson's disease: what is the role of positron emission tomography?
    Sawle GV
    Mov Disord; 1993 Jul; 8(3):271-7. PubMed ID: 8341290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluating dementia using PET: how do we put into clinical perspective what we know to date?
    Silverman DH; Phelps ME
    J Nucl Med; 2000 Nov; 41(11):1929-32. PubMed ID: 11079506
    [No Abstract]   [Full Text] [Related]  

  • 7. Positron emission tomography in the study of brain metabolism in psychiatric and neuropsychiatric disorders.
    Bench CJ; Dolan RJ; Friston KJ; Frackowiak RS
    Br J Psychiatry Suppl; 1990; (9):82-95. PubMed ID: 2291823
    [No Abstract]   [Full Text] [Related]  

  • 8. [Statistical diagnostic radiology].
    Uchida Y; Ito H; Iimori T; Kigawa T; Okada S; Minoshima S
    Nihon Hoshasen Gijutsu Gakkai Zasshi; 2002 Dec; 58(12):1563-72. PubMed ID: 12577014
    [No Abstract]   [Full Text] [Related]  

  • 9. PET imaging in Parkinsonism.
    Calne DB; Snow BJ
    Adv Neurol; 1993; 60():484-7. PubMed ID: 8420175
    [No Abstract]   [Full Text] [Related]  

  • 10. [Positron-emission tomographic studies of the brain in parkinsonism patients].
    Berezhkova LV
    Zh Nevrol Psikhiatr Im S S Korsakova; 1995; 95(6):93-7. PubMed ID: 8788992
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebral ischemia and Alzheimer's disease: critical role of PET and implications for therapeutic intervention.
    Alavi A; Clark C; Fazekas F
    J Nucl Med; 1998 Aug; 39(8):1363-5. PubMed ID: 9708508
    [No Abstract]   [Full Text] [Related]  

  • 12. Positron emission tomography in dementia of the Alzheimer type. A brief review with a case study.
    Berg G; Grady CL; Sundaram M; Haxby JV; Moore AM; White J; Heston L; Rapoport SI; Avioli LV
    Arch Intern Med; 1986 Oct; 146(10):2045-9. PubMed ID: 3490239
    [No Abstract]   [Full Text] [Related]  

  • 13. UCLA PET in Alzheimer's diagnosis gets nation's attention.
    J Nucl Med; 2002 Feb; 43(2):20N. PubMed ID: 11859863
    [No Abstract]   [Full Text] [Related]  

  • 14. Single photon emission tomographic brain images in dementia of the Alzheimer type.
    Hendrie HC; Wellman HN; Hall KS; Farlow MR; Brittain HM; Demyer MK
    Am J Psychiatry; 1987 Mar; 144(3):387-8. PubMed ID: 3493708
    [No Abstract]   [Full Text] [Related]  

  • 15. PET-based molecular imaging in neuroscience.
    Jacobs AH; Li H; Winkeler A; Hilker R; Knoess C; Rüger A; Galldiks N; Schaller B; Sobesky J; Kracht L; Monfared P; Klein M; Vollmar S; Bauer B; Wagner R; Graf R; Wienhard K; Herholz K; Heiss WD
    Eur J Nucl Med Mol Imaging; 2003 Jul; 30(7):1051-65. PubMed ID: 12764552
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotine receptors in the brain of patients with Alzheimer's disease. Studies with 11C-nicotine and positron emission tomography.
    Nordberg A; Hartvig P; Lilja A; Viitanen M; Amberla K; Lundqvist H; Andersson J; Nybäck H; Ulin J; Anderson Y
    Acta Radiol Suppl; 1991; 376():165-6. PubMed ID: 1666767
    [No Abstract]   [Full Text] [Related]  

  • 17. Regional dynamics of N-isopropyl-(123I)p-iodoamphetamine in human brain.
    Nishizawa S; Tanada S; Yonekura Y; Fujita T; Mukai T; Saji H; Fukuyama H; Miyoshi T; Harada K; Ishikawa M
    J Nucl Med; 1989 Feb; 30(2):150-6. PubMed ID: 2786930
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparability of FDG PET studies in probable Alzheimer's disease.
    Herholz K; Perani D; Salmon E; Franck G; Fazio F; Heiss WD; Comar D
    J Nucl Med; 1993 Sep; 34(9):1460-6. PubMed ID: 8355064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Positron-emission tomography in akinetic rigidity syndrome].
    Goldman S
    Rev Med Brux; 1995 Dec; 16(6):399-403. PubMed ID: 8570982
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Parkinson's disease: positron emission tomographic studies.
    Martin WR
    Semin Neurol; 1989 Dec; 9(4):345-50. PubMed ID: 2701779
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.